NCT03717064View on ClinicalTrials.gov

A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

December 17, 2018

Study Completion Date

December 17, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

RO7049389

RO7049389 will be taken orally, in tablet form, BID on Days 1-6 of Period 2.

DRUG

Pitavastatin

Pitavastatin will be taken orally, in tablet form, once on Day 1 of Period 1, and once on Day 4 of Period 2.

Trial Locations (1)

32117

Covance Research Unit - Daytona, Daytona Beach

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT03717064 - A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers | Biotech Hunter | Biotech Hunter